Fairscale Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Fairscale Capital's GILD Position: Q3 2026 in Review
Fairscale Capital held its Gilead Sciences (GILD) position steady in Q3 2026 at 74 shares worth $12.6K. The position accounts for 0.01% of the portfolio, ranked #312.
Fairscale Capital first reported a position in GILD in Q2 2024 and has held it in 10 quarters since. 2,348 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Fairscale Capital held 74 shares of Gilead Sciences worth $12.6K as of Q3 2026.
- Fairscale Capital left its Gilead Sciences share count unchanged in Q3 2026.
- Gilead Sciences made up 0.01% of Fairscale Capital's portfolio in Q3 2026, its #312 holding.
- Fairscale Capital first reported a position in Gilead Sciences in Q2 2024 and has held it in 10 quarters since.
- 2,348 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Fairscale Capital's 13F filing for Q3 2026, filed 4 Nov 2026.